Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.

TitleProceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.
Publication TypeJournal Article
Year of Publication2022
AuthorsHolstein, SA, Asimakopoulos, F, Azab, AKareem, Bianchi, G, Bhutani, M, Crews, LA, Cupedo, T, Giles, H, Gooding, S, Hillengass, J, John, L, Kaiser, S, Lee, L, Maclachlan, K, Pasquini, MC, Pichiorri, F, Shah, N, Shokeen, M, Shy, BR, Smith, EL, Verona, R, Usmani, SZ, McCarthy, PL
JournalTransplant Cell Ther
Volume28
Issue8
Pagination446-454
Date Published2022 Aug
ISSN2666-6367
KeywordsBone Marrow, Cell- and Tissue-Based Therapy, Clinical Trials as Topic, Humans, Multiple Myeloma
Abstract

The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations.

DOI10.1016/j.jtct.2022.05.019
Alternate JournalTransplant Cell Ther
PubMed ID35605882
PubMed Central IDPMC9357156
Grant ListU10 HL069294 / HL / NHLBI NIH HHS / United States
U24 HL138660 / HL / NHLBI NIH HHS / United States
R01 CA248493 / CA / NCI NIH HHS / United States
K08 CA245100 / CA / NCI NIH HHS / United States
R37 CA252040 / CA / NCI NIH HHS / United States
R01 CA252937 / CA / NCI NIH HHS / United States